Introduction: During the surge of the SARS-CoV-2 pandemic, studies revealed high complication and morbidity rates following surgical procedures in COVID-19 positive patients. Anesthetic and surgical societies swiftly developed strategies to mitigate these risks, including a recommended postponement of elective surgeries for a minimum of 7 weeks post-COVID infection. Nowadays, with a predominantly vaccinated population, it has become crucial to discern the influencing factors on post-COVID morbidity and mortality and a reevaluation of the existing recommendations pertaining to elective surgery.
View Article and Find Full Text PDFBackground: Textbook outcome is a valuable tool for assessing surgical outcomes. The aim of this study was to analyse textbook-outcome rates in the prospective Spanish National Registry of the Liver-First Approach (RENACI Project) and the factors influencing textbook-outcome achievement. Additionally, a model for assessing a procedure-specific textbook outcome for the liver-first approach was proposed.
View Article and Find Full Text PDFBackground: Criteria for resectability of colorectal liver metastases (CRLM) have been expanded over the last decade along with the improvement in chemotherapy.
Objective: Analyze the differences in several clinicopathological characteristics and overall survival (OS) between patients who underwent an R0 (tumour margin > 1 mm) or R1 (margin < 1 mm) resection.
Method: Retrospective study including 144 patients with CRLM who underwent a potentially curative liver surgery between 2010 and 2018.
Introduction: Intrabiliary growth of colorectal liver metastasis determines their capability of dissemination and relapse.
Case Report: 65-year-old woman underwent sigmoidectomy (2011) and left hepatectomy due to liver metastases affecting the bile tract (2014). In 2020 she developed a 2cm tumour in the union of both hepatic ducts.
Introduction: We evaluated the impacts of a series of novel histopathological factors on clinical-surgical outcomes and survival of patients who underwent surgery for colorectal cancer liver metastasis, with and without neoadjuvant chemotherapy.
Materials And Methods: A prospective database including 150 consecutive patients who underwent 183 hepatic resections for metastatic colorectal cancer was evaluated. Among them, 74 (49.